Vitamin E may slow functional decline in Patients with Alzheimer's disease and decrease caregiver burden.

Researchers from Minneapolis VA Health Care System and Icahn School of Medicine at Mount Sinai examined the effectiveness and safety of vitamin E‚ the drug called memantine‚ and the combination for treatment of functional decline in patients with mild to moderate AD‚ Xinhua News reported.

These patients were also taking anti-dementia drugs known as acetyl cholinesterase inhibitors said the findings published in the Journal of the American Medical Association.

The researchers found no significant increase in mortality with vitamin E. The annual mortality rate was 7.3 percent in the alpha tocopherol group compared with 9.4 percent for the placebo group.

Third-party Ads